|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Marimastat: the clinical development of a matrix metalloproteinase inhibitor 显示文摘 | Steward WP Thomas AL | 2000 | Expert Opin Investig Drugs2000，9，12： | 1 |
| 2 | Immediate andlate outcomes of transarterial coil occlusion of patent ductusarteriosus in dogs 显示文摘 | Campbell FE Thomas WP Miller SJ | 2006 | J Veterinary Intern Med2006，20，1： | 1 |
| 3 | Applications,complications,and outcomesof transvenous pacemaker implantation in 105 dogs (1997-2002)显示文摘 | Wess G Thomas WP Berger DM | 2006 | J Vet Intern Med2006，20，4： | 1 |
| 4 | Systemic irradiance signalling in tobacco 显示文摘 | Thomas P Woodward FI Quick WP 2003 | 2003 | New Phytologist2003，161，： | 1 |
| 5 | Standard criteria for an acceptable donor heart are restricting heart transplantation 显示文摘 | Valluvan J Satoshi F Thomas WP | 1996 | Ann Thorac Surg1996，62，5： | 1 |
| 6 | Bone grafts:A radiologic,histologic and Biomechanical model comparing autografts,allografts and free vascularized bone grafts显示文摘 | Andrew JW Thomas WP | 1984 | Plast Reconstr Surg1984，79，： | 1 |
| 7 | Marimastat:the clinical development of a matrix metalloproteinase inhibitor显示文摘 | Steward WP Thomas AL | 2000 | Expert Opin Investing Drugs2000，9，12： | 1 |
| 8 | Maristat:the clinical development of a matrix metalloproteinase inhibitor显示文摘 | Steward WP Thomas AL | 2000 | Expert Opin Investig Drugs2000，9，12： | 1 |
| 9 | Simulation model of Rhyzopertha dominica population dynamics in concrete grain bins显示文摘 | Paul WF David WH Thomas WP | 2004 | Journal of Stored Product Research2004，40，： | 1 |
| 10 | Murimastat:The clinical develpment of a matrix metalloproteinase inhibitor显示文摘 | Thomas A | 2000 | Expert Opin Investig Drugs2000，9，12： | 1 |
| 11 | Vaseular endothelial growth factor (VEGF) inhibition by small molecules 显示文摘 | Ahmed SI Thomas AL Steward WP | 2004 | J Chemother2004，16，4： | 1 |
| 12 | DNA marker linked to the Fore 2 Fusarium Wilt resistance genre in muskmelon MR-1显示文摘 | Wechter WP Dean RA Thomas CE | 1998 | Hort Science1998，33，2： | 1 |
| 13 | Identification of a randomly ampified polymorphic DNA marker Linked to the Fom 2 Fusarium wilt resistance gene in muskmelon MR-1 显示文摘 | Wechter WP Whitehead MP Thomas CE | 1995 | Phytopathology1995，85，： | 1 |
| 14 | Expanded phase Ⅰ/Ⅱ study of PTK787/ZK 222584 (PTK/ZK),a novel,oral angiogenesis inhibitor,in combination with FOLFOX-4 as first-line treatment for patients with metastatic colourectal显示文摘 | Steward WP Thomas A Morgan B | 2004 | Proc Am Soc Clin Oncol2004，23，： | 1 |
| 15 | Marimastat: the clinical development of a matrix metalloproteinase inhibitor 显示文摘 | Steward WP Thomas AL | 2000 | Expert Opin Investing Drugs2000，9，12： | 1 |
| 16 | Marimastat: the clinical development of a matrix metalloproteinase inhibitor显示文摘 | Steward WP Thomas AL | 2000 | Expert Opin Investing Drugs2000，9，12： | 1 |
| 17 | Two Languages are better than one显示文摘 | Thomas WP Collier VP | 1997 | Educational Leadership1997，55，4： | 1 |
| 18 | Experience and strategy for the molecular testing of Duchenne muscular dystrophy显示文摘 | Thomas WP Scott JB | 2005 | J Mol Diagn2005，7，3： | 1 |
| 19 | Identification of a random amplified polymorphic DNA marker linked to the Form 1 Fusarium Wilt resistance gene in muskmelon MR-I显示文摘 | Wechter WP Whitehead MP Thomas CE | 1995 | Phytopathology1995，85，： | 1 |
| 20 | Expanded phase Ⅰ/Ⅱstudy of PTK787/ZK 222584 (PTK/ZK),a novel,oral angiogenesis inhibitor,in combination with FOLFOX-4 as first-line treatment for patients with metastatic colorectal cancer显示文摘 | Steward WP Thomas A Morgan B | 2004 | Program/Proc Am Soc Clin Oncol2004，22，14： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员